ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintTitle ChevronIcon Twitter
Coronavirus

Beijing COVID strain comes from Southeast Asia, Harvard suggests

Variant that appeared in China may have returned via Europe and Asia

The virus found in the recent Beijing outbreak is an imported strain of COVID-19, according to the China Centre for Disease Control and Prevention.   © Reuters

SHANGHAI (Reuters) -- A strain of COVID-19 that has infected more than 300 people in Beijing since early June could have originated in South or Southeast Asia, according to a study by Harvard University researchers.

The outbreak in Beijing has raised concerns about China's vulnerability to a "second wave" of infections. The virus found in Beijing cases is an imported strain of COVID-19, according to the China Centre for Disease Control and Prevention.

The Harvard study, published on the preprint website medRxiv.org on Tuesday and which has still to be peer-reviewed, took three of the SARS-CoV-2 genome sequences collected in Beijing last month and compared them to 7,643 samples worldwide.

The three genomes showed the greatest resemblance to cases in Europe from February to May, and to cases in South and Southeast Asia from May to June.

They were also similar to a small number of infections seen in China in March, suggesting the strain could have appeared first in China and then returned to the country three months later, the authors said.

"As the most recent cases in these branches are almost exclusively from South(east) Asia, this could suggest that the new cases in Beijing were re-introduced by transmissions from South(east) Asia," they wrote.

The outbreak traced to Beijing's huge Xinfadi wholesale market on June 11 had infected 329 people by the end of Wednesday.

Quarantine restrictions and large-scale testing of residents began soon after the first cases were identified, and China also required all shipments of imported meat to be tested for COVID-19 before they could leave its ports.

The SARS-CoV-2 virus was believed to have originated in a market in the central Chinese city of Wuhan in December last year and has now infected more than 10 million people and killed more than 500,000 worldwide.

However, some studies suggest it could have been circulating much earlier after crossing the species barrier from horseshoe bats native not only to southwest China, but also Laos and Myanmar.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Try 1 month for $0.99

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends October 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to Nikkei Asia has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more